BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yanai H, Masui Y, Yoshikawa R, Kunimatsu J, Kaneko H. Dipeptidyl peptidase-4 inhibitor for steroid-induced diabetes. World J Diabetes 2010; 1(3): 99-100 [PMID: 21537433 DOI: 10.4239/wjd.v1.i3.99]
URL: https://www.wjgnet.com/1948-9358/full/v1/i3/99.htm
Number Citing Articles
1
Yoshihide Fujigaki. Alogliptin improves steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levelsMedical Science Monitor 2014; 20: 587 doi: 10.12659/MSM.889872
2
Anna Mehlich, Marek Bolanowski, Dawid Mehlich, Przemysław Witek. Medical treatment of Cushing’s disease with concurrent diabetes mellitusFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1174119
3
Satoshi Ito, Hiroshi Ogishima, Yuya Kondo, Makoto Sugihara, Taichi Hayashi, Yusuke Chino, Daisuke Goto, Isao Matsumoto, Takayuki Sumida. Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseasesModern Rheumatology 2013;  doi: 10.1007/s10165-013-0834-y
4
Mattia Barbot, Filippo Ceccato, Carla Scaroni. Diabetes Mellitus Secondary to Cushing’s DiseaseFrontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00284
5
Al’bert Yu. Selimov, Lyudmila N. Eliseeva, Valeriya P. Kurinnaya, Sergei P. Oranskii. GLUCOSE EXCHANGE DISORDERS IN PATIENTS TAKING GLUCOCORTICOSTEROIDS: FEATURES OF CLINICAL MANIFESTATIONS AND CORRECTIONKuban Scientific Medical Bulletin 2019; 26(1): 209 doi: 10.25207/1608-6228-2019-26-1-209-218
6
Takayuki Katsuyama, Ken-Ei Sada, Sayaka Namba, Haruki Watanabe, Eri Katsuyama, Toshio Yamanari, Jun Wada, Hirofumi Makino. Risk factors for the development of glucocorticoid-induced diabetes mellitusDiabetes Research and Clinical Practice 2015; 108(2): 273 doi: 10.1016/j.diabres.2015.02.010
7
Parag Shah, Sanjay Kalra, Yogesh Yadav, Nilakshi Deka, Tejal Lathia, Jubbin Jagan Jacob, Sunil Kumar Kota, Saptarshi Bhattacharya, Sharvil S Gadve, KAV Subramanium, Joe George, Vageesh Iyer, Sujit Chandratreya, Pankaj Kumar Aggrawal, Shailendra Kumar Singh, Ameya Joshi, Chitra Selvan, Gagan Priya, Atul Dhingra, Sambit Das. Management of Glucocorticoid-Induced HyperglycemiaDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 1577 doi: 10.2147/DMSO.S330253
8
P. Hyma, K. Abbulu. Formulation and characterisation of self-microemulsifying drug delivery system of pioglitazoneBiomedicine & Preventive Nutrition 2013; 3(4): 345 doi: 10.1016/j.bionut.2013.09.005
9
Sunghwan Suh, Mi Kyoung Park. Management of Steroid-induced HyperglycemiaThe Journal of Korean Diabetes 2016; 17(3): 174 doi: 10.4093/jkd.2016.17.3.174
10
Aleksandra Ostrowska-Czyżewska, Wojciech Zgliczyński, Lucyna Bednarek-Papierska, Beata Mrozikiewicz-Rakowska. Is It Time for a New Algorithm for the Pharmacotherapy of Steroid-Induced Diabetes?Journal of Clinical Medicine 2024; 13(19): 5801 doi: 10.3390/jcm13195801
11
Tomohiro Matsuhashi, Motoaki Sano, Keiichi Fukuda, Shun Kohsaka, Yoshihiko Suzuki. Sitagliptin counteracts seasonal fluctuation of glycemic controlWorld Journal of Diabetes 2012; 3(6): 118-122 doi: 10.4239/wjd.v3.i6.118
12
Sarah Noetzlin, Gautier Breville, Jörg D. Seebach, Giacomo Gastaldi. Short-term glucocorticoid-related side effects and adverse reactions: a narrative review and practical approachSwiss Medical Weekly 2022; 152(0102): w30088 doi: 10.4414/SMW.2022.w30088
13
Resal Raj, Jasvinder Singh Bhatti, Sanjay Kumar Badada, Pramod W. Ramteke. Genetic basis of dyslipidemia in disease precipitation of coronary artery disease (CAD) associated type 2 diabetes mellitus (T2DM)Diabetes/Metabolism Research and Reviews 2015; 31(7): 663 doi: 10.1002/dmrr.2630
14
Sunghwan Suh, Mi Kyoung Park. Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked ProblemEndocrinology and Metabolism 2017; 32(2): 180 doi: 10.3803/EnM.2017.32.2.180